4D Molecular Therapeutics Inc
NASDAQ:FDMT
4D Molecular Therapeutics Inc
NASDAQ:FDMT
Price:
8.47
USD
0.77%
Market Closed
Market Cap:
$432.4m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
4D Molecular Therapeutics Inc
NASDAQ:FDMT
|
US |
|
Fletcher Building Ltd
F:FLQ
|
NZ |
|
Taskus Inc
NASDAQ:TASK
|
US |
|
W
|
Warrix Sport PCL
SET:WARRIX
|
TH |
|
Aptose Biosciences Inc
TSX:APS
|
CA |
|
Japan Hotel Reit Investment Corp
TSE:8985
|
JP |
|
SAP SE
F:SAP
|
DE |
|
D
|
Dr Martens PLC
OTC:DOCMF
|
UK |
|
Plazza AG
SIX:PLAN
|
CH |
Wall St Price Targets
FDMT Price Targets Summary
4D Molecular Therapeutics Inc
4D Molecular Therapeutics Inc
Wall Street analysts forecast FDMT stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for FDMT is 28.79 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.
Lowest Forecast
Price Target
17.17
USD
103% Upside
Average Forecast
Price Target
28.79
USD
240% Upside
Highest Forecast
Price Target
37.8
USD
346% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is FDMT's stock price target?
Price Target
28.79
USD
28.79
USD
According to Wall Street analysts, the average 1-year price target for FDMT is 28.79 USD with a low forecast of 17.17 USD and a high forecast of 37.8 USD.
What is the Revenue forecast for 4D Molecular Therapeutics Inc?
Projected CAGR
40%
40%
Over the last 7 years, the compound annual growth rate for Revenue has been 29%. The projected CAGR for the next 8 years is 40%.
